Your browser doesn't support javascript.
loading
Radiosensitization and Radioprotection by Curcumin in Glioblastoma and Other Cancers.
Zoi, Vasiliki; Galani, Vasiliki; Tsekeris, Pericles; Kyritsis, Athanasios P; Alexiou, George A.
Afiliação
  • Zoi V; Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece.
  • Galani V; Department of Anatomy Histology-Embryology, School of Medicine, University of Ioannina, 45110 Ioannina, Greece.
  • Tsekeris P; Department of Radiation Oncology, University of Ioannina, 45110 Ioannina, Greece.
  • Kyritsis AP; Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece.
  • Alexiou GA; Neurosurgical Institute, University of Ioannina, 45500 Ioannina, Greece.
Biomedicines ; 10(2)2022 Jan 28.
Article em En | MEDLINE | ID: mdl-35203521
ABSTRACT
Radiation therapy plays an important role in almost every cancer treatment. However, radiation toxicity to normal tissues, mainly due to the generation of reactive free radicals, has limited the efficacy of radiotherapy in clinical practice. Curcumin has been reported to possess significant antitumor properties. Although curcumin can sensitize cancer cells to irradiation, healthy cells are much less sensitive to this effect, and thus, curcumin is thought to be a potent, yet safe anti-cancer agent. In this review, a summary of the role of curcumin as both a radiosensitizer and radioprotector has been presented, based on the most recent data from the experimental and clinical evaluation of curcumin in different cancer cell lines, animal models, and human patients.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Grécia